ID
int64 1
9.11k
| age
float64 18
102
| death
int64 0
1
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| d.time
int64 3
2.03k
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3,501 | 57.65399 | 1 | male | 0 | 3 | 1,142 | CHF | COPD/CHF/Cirrhosis | 3 | null | null | 0 | 2,742.049 | 2,030.5508 | null | 6 | black | 15.599609 | 19 | 0.914917 | 0.856934 | 1 | 0 | 0 | no | null | null | no dnr | 3 | 63 | 6.699219 | 60 | 22 | 37.19531 | null | null | 1 | 1.399902 | 140 | null | null | null | null | null | null | null | 1.937988 |
3,502 | 45.18799 | 1 | male | 1 | 20 | 20 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | null | 26 | 121,575.062 | 80,014.1875 | null | 53.666657 | white | 37.898438 | 63 | 0.41095 | 0.291992 | 13 | 0 | 0 | no | 0.1 | 0.001 | dnr after sadm | 13 | 74 | 14 | 142 | 36 | 39.59375 | 87.14062 | null | 2 | 2 | 134 | 7.40918 | null | null | null | null | 1 | <2 mo. follow-up | 1 |
3,503 | 53.25098 | 1 | male | 1 | 10 | 10 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | $11-$25k | 26 | 83,062.625 | 51,944.4688 | null | 38.5 | white | 24.898438 | 26 | 0.701904 | 0.611938 | 10 | 1 | 0 | no | 0.85 | 0.7 | dnr after sadm | 10 | 87 | 10.898438 | 92 | 8 | 37.19531 | 116.35938 | null | null | 1.5 | 145 | 7.419922 | null | null | null | null | 2 | <2 mo. follow-up | 2 |
3,504 | 47.86298 | 1 | female | 1 | 8 | 8 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 12 | null | 44 | 23,279.203 | 16,235.8438 | null | 47 | black | 46.09375 | 59 | 0.077988 | 0.011999 | 1 | 0 | 0 | no | 0.1 | 0.001 | no dnr | 8 | 89 | 11.599609 | 110 | 11 | 35.89844 | 157.5 | null | 39 | 3 | 152 | 7.419922 | null | null | null | null | 4 | <2 mo. follow-up | 4 |
3,505 | 64.61896 | 0 | male | 0 | 10 | 1,876 | Colon Cancer | Cancer | 1 | 26 | $11-$25k | 0 | 21,980.688 | 14,755.4375 | null | 25.5 | white | 20.398438 | 21 | 0.767944 | 0.518921 | 1 | 0 | 0 | metastatic | 1 | 1 | no dnr | 10 | 102 | 7.699219 | 78 | 32 | 38.59375 | 390 | null | 0.5 | 0.799927 | 134 | 7.419922 | null | null | null | 0 | null | null | 0.4948 |
3,506 | 25.47299 | 1 | male | 0 | 18 | 28 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 9 | under $11k | 41 | 51,170.219 | 36,150.0625 | null | 27 | white | 32 | 60 | 0.630981 | 0.527954 | 11 | 0 | 0 | no | null | null | dnr after sadm | 4 | 113 | 22.796875 | 134 | 52 | 39 | 423.3125 | null | null | 3.599609 | 137 | 7.329102 | null | null | null | null | 3 | <2 mo. follow-up | 3 |
3,507 | 68.84595 | 1 | male | 0 | 13 | 764 | COPD | COPD/CHF/Cirrhosis | 1 | 13 | >$50k | 0 | 11,347.469 | 8,073.2383 | null | 12 | white | 19.199219 | 20 | 0.85498 | 0.760986 | 1 | 0 | 0 | no | 0.99 | 0.95 | no dnr | 13 | 117 | 9.599609 | 112 | 18 | 36 | 266.625 | null | 0.399963 | 1 | 142 | 7.419922 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
3,508 | 66.86694 | 1 | male | 1 | 18 | 18 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 55 | 148,144.625 | 92,974.3125 | null | 52 | black | 46.296875 | 80 | 0.019997 | 0.004 | 9 | 0 | 0 | no | null | null | no dnr | 18 | 58 | 24.296875 | 114 | 27 | 37 | 166 | null | 30 | 5.699219 | 155 | 7.40918 | null | null | null | null | null | <2 mo. follow-up | 3.398926 |
3,509 | 39.93198 | 1 | male | 1 | 33 | 33 | MOSF w/Malig | ARF/MOSF | 1 | 12 | null | 0 | 202,703.625 | 137,771.25 | null | 36.5 | white | 33.796875 | 35 | 0.273987 | 0.165985 | 40 | 0 | 0 | metastatic | 0.1 | 0.001 | dnr after sadm | 31 | 90 | 1 | 114 | 16 | 38 | 148.875 | 2.5 | 3.799805 | 1.5 | 142 | 7.479492 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
3,510 | 66.97894 | 0 | male | 0 | 92 | 1,873 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | null | 0 | 306,380.25 | 212,576.375 | null | 36.25 | white | 19.199219 | 28 | 0.813965 | 0.751953 | 14 | 0 | 0 | no | null | null | no dnr | 92 | 117 | 17.898438 | 80 | 28 | 38 | 233.3125 | null | null | 1.599854 | 133 | 7.449219 | null | null | null | null | null | null | 2.20459 |
3,511 | 75.59497 | 1 | female | 1 | 16 | 16 | Lung Cancer | Cancer | 1 | 10 | null | 0 | 13,365.695 | 10,269.4922 | null | 7 | white | 31.597656 | 20 | 0.287964 | 0.045998 | 1 | 0 | 0 | metastatic | 0.5 | 0.2 | dnr after sadm | 3 | 91 | 7.5 | 96 | 20 | 35 | 371.375 | 2.399902 | 0.399963 | 0.799927 | 140 | 7.339844 | null | null | null | 3 | 3 | <2 mo. follow-up | 3 |
3,512 | 61.00497 | 1 | male | 0 | 5 | 550 | COPD | COPD/CHF/Cirrhosis | 3 | 6 | null | 0 | 3,199.719 | 2,482.4902 | null | 7 | white | 17.398438 | 20 | 0.902954 | 0.836914 | 1 | 0 | 0 | no | 0.99 | 0.85 | no dnr | 5 | 128 | 6.699219 | 100 | 20 | 36.5 | 257.125 | null | 0.199982 | 1.099854 | 132 | 7.40918 | null | null | null | null | null | no(M2 and SIP pres) | 2.38916 |
3,513 | 75.65796 | 1 | male | 0 | 57 | 226 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 14 | $11-$25k | 44 | 88,611.688 | 59,934.1875 | null | 22.25 | white | 18.898438 | 17 | 0.66394 | 0.566895 | 6 | 0 | 0 | no | 0.7 | 0.5 | dnr after sadm | 1 | 107 | 5.5 | 48 | 10 | 37.39844 | 323.3125 | 2.599609 | null | 0.899902 | 136 | 7.5 | null | null | null | null | 0 | adl>=4 (>=5 if sur) | 0 |
3,514 | 61.86697 | 1 | male | 1 | 8 | 8 | MOSF w/Malig | ARF/MOSF | 2 | 16 | >$50k | 0 | 74,204.75 | 51,113.4062 | null | 49.5 | white | 47.59375 | 73 | 0.029999 | 0.007999 | 38 | 0 | 0 | yes | 0 | 0 | dnr after sadm | 8 | 63 | 0.299988 | 146 | 17 | 36.69531 | 89.32812 | null | null | 2.799805 | 127 | 7.389648 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
3,515 | 80.80194 | 1 | male | 1 | 44 | 44 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 20 | $25-$50k | 55 | 133,353.125 | 88,074.3125 | null | 42 | white | 34 | 45 | 0.15799 | 0.076996 | 7 | 1 | 0 | no | 0.1 | 0.001 | dnr after sadm | 3 | 99 | 21.398438 | 110 | 10 | 36.59375 | 122.4375 | 2.399902 | 1.299805 | 5.899414 | 151 | 7.449219 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
3,516 | 72.65198 | 1 | male | 1 | 3 | 3 | Coma | Coma | 1 | null | null | 100 | 20,842.734 | 14,142.6172 | null | 17 | white | 70.59375 | 78 | 0 | 0 | 4 | 0 | 0 | no | null | null | dnr before sadm | -1 | 0 | 6.199219 | 0 | 0 | 38 | 312.5 | null | null | 2.599609 | 142 | 7.469727 | null | null | null | null | null | <2 mo. follow-up | 1.836426 |
3,517 | 47.39999 | 1 | female | 0 | 7 | 461 | Colon Cancer | Cancer | 1 | 15 | >$50k | 0 | 9,032.297 | 6,259.3008 | null | 6.5 | white | 15.398438 | 6 | 0.863892 | 0.695923 | 1 | 0 | 0 | metastatic | null | null | no dnr | 7 | 93 | 5.199219 | 68 | 24 | 37.39844 | null | null | 0.399963 | 0.5 | 140 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
3,518 | 76.11499 | 1 | female | 0 | 6 | 804 | CHF | COPD/CHF/Cirrhosis | 3 | 10 | under $11k | 0 | 6,222.898 | 4,641.1328 | null | 10 | black | 20.796875 | 32 | 0.816895 | 0.702881 | 1 | 1 | 0 | no | 0.9 | 0.85 | no dnr | 6 | 102 | 6.699219 | 68 | 20 | 36.59375 | 508 | null | null | 3.199707 | 137 | 7.379883 | null | null | null | 0 | 1 | no(M2 and SIP pres) | 1 |
3,519 | 43.67999 | 1 | male | 0 | 5 | 849 | Colon Cancer | Cancer | 1 | null | null | 0 | 3,973.898 | 3,191.6055 | null | 11 | white | 13.099609 | 6 | 0.889893 | 0.75 | 1 | 0 | 0 | metastatic | 0.99 | 0.5 | no dnr | 5 | 95 | 7.099609 | 74 | 19 | 37.19531 | null | null | null | 1 | 138 | null | null | null | null | null | null | null | 1.622559 |
3,520 | 50.15997 | 1 | female | 1 | 89 | 89 | CHF | COPD/CHF/Cirrhosis | 2 | 16 | $25-$50k | 0 | 144,129.25 | 96,060.75 | null | 26.75 | black | 24.597656 | 40 | 0.855957 | 0.761963 | 1 | 0 | 0 | no | 0.8 | 0.6 | dnr after sadm | 88 | 79 | 10.099609 | 118 | 36 | 37.5 | 428.5625 | 3.199707 | 3.199707 | 1.199951 | 138 | 7.5 | null | null | null | 0 | null | adl>=4 (>=5 if sur) | 0.4948 |
3,521 | 63.80798 | 1 | male | 0 | 6 | 384 | CHF | COPD/CHF/Cirrhosis | 4 | 12 | null | 0 | 3,234.049 | 2,703.2148 | null | 11 | white | 14.5 | 9 | 0.910889 | 0.849976 | 1 | 0 | 0 | no | null | null | no dnr | 6 | 84 | 6.199219 | 90 | 20 | 36.79688 | null | null | null | 0.899902 | 141 | null | null | null | null | 0 | 1 | no(M2 and SIP pres) | 1 |
3,522 | 41.79599 | 1 | female | 1 | 3 | 3 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | null | null | 0 | 41,557.875 | 23,583.0469 | null | 68 | black | 79 | 90 | 0 | 0 | 1 | 0 | 0 | no | 0.3 | 0.25 | no dnr | 3 | 0 | 20.699219 | 0 | 0 | 39.69531 | 531 | null | 0.399963 | 7.099609 | 168 | 7.469727 | null | null | null | 0 | null | <2 mo. follow-up | 0.4948 |
3,523 | 49.94098 | 1 | female | 0 | 12 | 797 | Colon Cancer | Cancer | 1 | 14 | >$50k | 0 | 27,833.797 | 18,704.7812 | null | 21.5 | white | 17.296875 | 13 | 0.839966 | 0.648926 | 1 | 0 | 0 | metastatic | 1 | 1 | no dnr | 12 | 103 | 7.399414 | 118 | 8 | 36.5 | 370 | 3.599609 | 0.199982 | 0.899902 | 142 | 7.349609 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
3,524 | 66.05096 | 1 | female | 0 | 5 | 284 | Lung Cancer | Cancer | 1 | 12 | $25-$50k | 0 | 4,287.848 | 2,880.5723 | null | 14 | hispanic | 15.898438 | 9 | 0.727905 | 0.454956 | 1 | 0 | 0 | metastatic | 1 | 0.8 | no dnr | 5 | 87 | 7.899414 | 60 | 20 | 36.39844 | null | null | 0.199982 | 0.799927 | 143 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
3,525 | 63.82199 | 1 | male | 1 | 15 | 15 | MOSF w/Malig | ARF/MOSF | 3 | 11 | $11-$25k | 9 | 30,126.047 | 22,027.9531 | null | 25 | white | 23.5 | 33 | 0.608887 | 0.50293 | 1 | 0 | 0 | metastatic | 0.5 | 0.3 | dnr after sadm | 13 | 109 | 44.09375 | 110 | 34 | 35.89844 | 255.8125 | 3.199707 | 0.199982 | 0.799927 | 143 | 7.439453 | null | null | null | null | 1 | <2 mo. follow-up | 1 |
3,526 | 60.01599 | 1 | male | 1 | 4 | 4 | MOSF w/Malig | ARF/MOSF | 2 | null | null | 44 | 29,811.031 | 19,366.2188 | null | 53 | white | 50.398438 | 98 | 0.001 | 0 | 8 | 1 | 0 | yes | 0.01 | 0.000001 | dnr after sadm | 4 | 44 | 0.099991 | 180 | 12 | 37.29688 | 252.5 | 1.899902 | 4.699219 | 3.799805 | 153 | 7.289062 | null | null | null | null | null | <2 mo. follow-up | 2.475098 |
3,527 | 71.75598 | 1 | male | 0 | 16 | 270 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 8 | under $11k | 9 | 59,008.219 | 39,635.0312 | null | 23.333328 | black | 27.597656 | 38 | 0.60791 | 0.501953 | 11 | 0 | 0 | no | 0.85 | 0.82 | no dnr | 16 | 63 | 24.796875 | 110 | 18 | 36.39844 | 170 | 2.599609 | 0.899902 | 2.099609 | 140 | 7.5 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
3,528 | 39.34598 | 0 | female | 0 | 13 | 1,856 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | under $11k | 0 | null | null | null | 23 | black | 25.199219 | 36 | 0.856934 | 0.806885 | 2 | 0 | 0 | no | 0.75 | 0.7 | no dnr | 13 | 114 | 20 | 118 | 40 | 37 | 442.8125 | null | 2.299805 | 1.199951 | 146 | 7.429688 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
3,529 | 66.22595 | 1 | male | 0 | 17 | 708 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 17 | null | 0 | 34,187.938 | 24,100.2969 | null | 9.333328 | white | 25.296875 | 18 | 0.715942 | 0.628906 | 14 | 0 | 0 | no | 0.5 | 0.4 | no dnr | 17 | 108 | 8.798828 | 70 | 26 | 35.59375 | 142.84375 | null | null | 0.5 | 138 | 7.30957 | null | null | null | null | 6 | adl>=4 (>=5 if sur) | 6 |
3,530 | 29.55499 | 1 | female | 1 | 6 | 6 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | $11-$25k | 0 | 51,709.438 | 33,807.0938 | null | 59 | black | 48.5 | 74 | 0.349976 | 0.232971 | 10 | 0 | 0 | no | 0.05 | 0.000125 | dnr after sadm | 5 | 47 | 18.398438 | 112 | 30 | 35.89844 | 90 | null | 3.599609 | 5.799805 | 142 | 7.529297 | null | null | null | null | 2 | <2 mo. follow-up | 2 |
3,531 | 69.90594 | 1 | male | 0 | 5 | 929 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 9 | $25-$50k | 0 | 4,728.047 | 3,503.3516 | null | 14 | white | 17.898438 | 20 | 0.766968 | 0.629883 | 1 | 0 | 0 | no | 0.85 | 0.5 | no dnr | 5 | 81 | 9.199219 | 80 | 18 | 37.29688 | null | 3.199707 | 6.099609 | 1 | 140 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
3,532 | 56.97998 | 1 | male | 0 | 18 | 127 | MOSF w/Malig | ARF/MOSF | 2 | 12 | $11-$25k | 0 | 29,052.234 | 19,552.2812 | null | 15.666664 | white | 26 | 38 | 0.644897 | 0.544922 | 2 | 0 | 0 | yes | 0.8 | 0.5 | no dnr | 18 | 89 | 100 | 90 | 36 | 38.79688 | 133.3125 | null | null | 1.599854 | 137 | 7.459961 | null | null | null | 0 | 0 | adl>=4 (>=5 if sur) | 0 |
3,533 | 57.81497 | 1 | male | 1 | 22 | 22 | Lung Cancer | Cancer | 1 | 10 | $25-$50k | 0 | 23,437.938 | 16,626.1875 | null | 11.666664 | white | 26 | 10 | 0.511963 | 0.190979 | 1 | 0 | 0 | metastatic | 0.1 | 0.001 | dnr after sadm | 11 | 88 | 19.097656 | 100 | 18 | 36 | null | 2.899902 | 0.199982 | 0.899902 | 136 | null | null | null | null | 1 | 0 | <2 mo. follow-up | 0 |
3,534 | 61.32498 | 1 | male | 0 | 10 | 25 | MOSF w/Malig | ARF/MOSF | 1 | null | null | 61 | 33,008.531 | 24,771.1094 | null | 29 | white | 19 | 22 | 0.488953 | 0.370972 | 1 | 0 | 0 | metastatic | 0 | 0 | dnr after sadm | 3 | 131 | 15.599609 | 48 | 8 | 37.29688 | 302.8125 | 2.699707 | 0.299988 | 1.299805 | 146 | 7.5 | null | null | null | null | null | <2 mo. follow-up | 2.858398 |
3,535 | 76.11798 | 1 | male | 0 | 11 | 510 | CHF | COPD/CHF/Cirrhosis | 3 | 12 | $11-$25k | 0 | 5,847.648 | 4,985.293 | null | 9 | white | 16.5 | 25 | 0.865967 | 0.778931 | 1 | 0 | 0 | no | null | null | no dnr | 11 | 97 | 4.199219 | 74 | 20 | 35.79688 | null | 4 | 2.099609 | 1.799805 | 140 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
3,536 | 72.94995 | 1 | female | 1 | 14 | 14 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | 3 | null | 0 | 73,442.438 | 46,502.6562 | null | 36 | black | 19.296875 | 31 | 0.831909 | 0.773926 | 2 | 1 | 0 | no | null | null | dnr after sadm | 10 | 65 | 7.899414 | 110 | 8 | 37.89844 | 356.625 | 2.5 | 0.399963 | 1.799805 | 132 | 7.40918 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
3,537 | 26.92699 | 1 | male | 1 | 35 | 35 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 10 | under $11k | 0 | 141,803.25 | 94,806 | null | 34 | other | 40.195313 | 70 | 0.61499 | 0.509888 | 7 | 0 | 0 | no | 0.1 | 0.001 | dnr after sadm | 34 | 67 | 16.796875 | 140 | 36 | 37.5 | 130 | 2.799805 | 5.5 | 5.399414 | 134 | 7.289062 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
3,538 | 77.05396 | 1 | female | 1 | 5 | 5 | Coma | Coma | 2 | null | null | 100 | 9,438.594 | 7,084.5703 | null | 25 | black | 18.898438 | 32 | 0.230988 | 0.165985 | 1 | 1 | 1 | no | null | null | dnr after sadm | 4 | 131 | 12.798828 | 112 | 10 | 39.09375 | 366.625 | null | 0.299988 | 0.799927 | 142 | 7.459961 | null | null | null | null | null | <2 mo. follow-up | 4.424805 |
3,539 | 71.52594 | 1 | male | 1 | 53 | 53 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | 7 | $11-$25k | 41 | 238,583.125 | 160,377.875 | null | 32.5 | white | 26.898438 | 38 | 0.442993 | 0.323975 | 43 | 1 | 0 | no | 1 | 1 | dnr after sadm | 48 | 80 | 6.299805 | 110 | 39 | 36.09375 | 287.5 | 2.5 | 0.399963 | 2 | 152 | 7.399414 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
3,540 | 43.31799 | 1 | male | 0 | 6 | 19 | Cirrhosis | COPD/CHF/Cirrhosis | 0 | 16 | $25-$50k | 0 | 3,554.6 | 2,829.8418 | null | 9 | white | 26.199219 | 32 | 0.789917 | 0.662964 | 1 | 0 | 0 | no | 0.95 | 0.6 | no dnr | 6 | 103 | 8.5 | 76 | 20 | 36.69531 | 438.0625 | 3 | 6.099609 | 1.699951 | 126 | 7.40918 | null | null | null | 1 | 1 | <2 mo. follow-up | 1 |
3,541 | 63.12399 | 1 | female | 1 | 14 | 14 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | null | 44 | 80,263.875 | 54,229.2812 | null | 37.333313 | white | 27.398438 | 47 | 0.535889 | 0.420959 | 5 | 0 | 0 | no | null | null | dnr after sadm | 14 | 87 | 0.799927 | 76 | 10 | 36.59375 | 293.3125 | 2.5 | null | 7.399414 | 136 | 7.439453 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
3,542 | 72.03595 | 1 | female | 0 | 23 | 923 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 16 | $25-$50k | 0 | null | null | null | 10 | white | 23.097656 | 44 | 0.781982 | 0.710938 | 2 | 1 | 0 | no | 0.75 | 0.7 | no dnr | 23 | 123 | 11.699219 | 78 | 25 | 35.89844 | 310 | null | null | 2.099609 | 136 | 7.399414 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
3,543 | 71.79199 | 1 | female | 1 | 7 | 7 | MOSF w/Malig | ARF/MOSF | 1 | 12 | $11-$25k | 61 | 48,463.688 | 32,859.2812 | null | 38.5 | white | 38.195313 | 67 | 0.008999 | 0.001 | 9 | 0 | 0 | metastatic | null | null | dnr after sadm | 6 | 63 | 7.099609 | 110 | 25 | 36 | 220 | 2.799805 | 15.298828 | 3.599609 | 130 | 7.449219 | null | null | null | null | 1 | <2 mo. follow-up | 1 |
3,544 | 65.97894 | 1 | male | 0 | 12 | 421 | Lung Cancer | Cancer | 2 | 7 | null | 0 | 13,066.297 | 9,421.9062 | null | 10 | white | 14.398438 | 13 | 0.754883 | 0.498962 | 1 | 0 | 0 | metastatic | 0.9 | 0.5 | no dnr | 12 | 105 | 7.799805 | 74 | 18 | 36.59375 | null | null | 0.299988 | 0.699951 | 141 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
3,545 | 66.15698 | 1 | male | 0 | 3 | 78 | Lung Cancer | Cancer | 1 | null | null | 0 | 3,142.35 | 2,077.5918 | null | 8 | white | 16.097656 | 9 | 0.721924 | 0.44696 | 1 | 0 | 0 | metastatic | null | null | no dnr | 3 | 99 | 3.899902 | 88 | 20 | 36 | null | null | 0.199982 | 0.799927 | 135 | null | null | null | null | null | null | null | 1.993897 |
3,546 | 67.74298 | 1 | male | 0 | 8 | 1,530 | CHF | COPD/CHF/Cirrhosis | 2 | 18 | $11-$25k | 0 | 3,384.398 | 3,038.7207 | null | 7 | white | 17.699219 | 13 | 0.876953 | 0.794922 | 1 | 0 | 0 | no | 0.9 | 0.8 | no dnr | 8 | 93 | 6.399414 | 54 | 20 | 36.09375 | null | null | 0.799927 | 1.299805 | 140 | null | null | null | null | 0 | 0 | null | 0 |
3,547 | 58.48599 | 1 | female | 0 | 5 | 60 | Lung Cancer | Cancer | 1 | null | null | 0 | 3,006.998 | 2,284.6152 | null | 12 | white | 16.597656 | 15 | 0.730957 | 0.458984 | 1 | 0 | 0 | metastatic | 0 | 0 | dnr after sadm | 2 | 81 | 7.799805 | 100 | 16 | 38.09375 | 238.09375 | null | 0.5 | 0.599976 | 135 | 7.299805 | null | null | null | null | null | null | 2.708496 |
3,548 | 59.75098 | 0 | male | 0 | 245 | 1,846 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 2 | under $11k | 37 | 405,592 | 275,511.75 | null | 49.5 | white | 18.796875 | 27 | 0.767944 | 0.692993 | 5 | 0 | 0 | no | null | null | no dnr | 245 | 98 | 9.298828 | 104 | 8 | 40 | 292.5 | 3.299805 | null | 1.399902 | 142 | 7.5 | null | null | null | null | null | null | 2.061035 |
3,549 | 87.52899 | 1 | male | 1 | 3 | 3 | Coma | Coma | 0 | null | null | 100 | 9,511.203 | 6,827.6094 | null | 27 | black | 71 | 74 | 0 | 0 | 1 | 0 | 0 | no | 0.05 | 0.000125 | no dnr | 3 | 0 | 9.298828 | 0 | 0 | 36.59375 | 260 | 4.199219 | 0.399963 | 2.299805 | 141 | 7.379883 | null | null | null | null | null | <2 mo. follow-up | 2.178223 |
3,550 | 43.09097 | 1 | male | 0 | 11 | 1,358 | CHF | COPD/CHF/Cirrhosis | 1 | 12 | $11-$25k | 0 | 9,515.945 | 7,197.6836 | null | 13 | white | 17 | 11 | 0.930908 | 0.881958 | 1 | 0 | 0 | no | null | null | no dnr | 11 | 101 | 9.199219 | 86 | 20 | 35.79688 | 819 | null | 1.399902 | 1.099854 | 135 | 7.489258 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
3,551 | 76.06598 | 1 | male | 0 | 4 | 486 | CHF | COPD/CHF/Cirrhosis | 2 | null | null | 0 | 2,045.55 | 1,734.7861 | null | 7 | white | 22.5 | 35 | 0.791992 | 0.665894 | 1 | 0 | 0 | no | null | null | no dnr | 4 | 79 | 8.898438 | 64 | 16 | 35.59375 | 285.6875 | null | null | 2.599609 | 138 | 7.419922 | null | null | null | null | null | null | 2.812988 |
3,552 | 67.64398 | 1 | male | 0 | 6 | 172 | Lung Cancer | Cancer | 1 | 16 | $25-$50k | 0 | 6,064.5 | 3,969.1719 | null | 14 | white | 13.699219 | 11 | 0.762939 | 0.510986 | 1 | 0 | 0 | metastatic | 1 | 0.9 | no dnr | 6 | 93 | 9.699219 | 68 | 18 | 36.79688 | null | null | 0.299988 | 1 | 139 | null | null | null | null | 1 | 1 | no(M2 and SIP pres) | 1 |
3,553 | 56.06299 | 1 | female | 1 | 25 | 25 | Cirrhosis | COPD/CHF/Cirrhosis | 1 | 18 | >$50k | 0 | 141,836.875 | 94,576.6875 | null | 36.75 | asian | 24.097656 | 33 | 0.746948 | 0.601929 | 1 | 0 | 0 | no | 0.6 | 0.4 | dnr after sadm | 19 | 81 | 7 | 84 | 20 | 36.5 | null | 2.599609 | 21.5 | 1.299805 | 135 | null | null | null | null | null | 6 | <2 mo. follow-up | 6 |
3,554 | 77.01599 | 0 | female | 0 | 9 | 1,844 | MOSF w/Malig | ARF/MOSF | 2 | null | null | 0 | null | null | null | 21 | white | 23.898438 | 40 | 0.616943 | 0.511963 | 1 | 0 | 0 | metastatic | null | null | no dnr | 9 | 113 | 34.796875 | 110 | 10 | 36.79688 | 400 | 1.399902 | null | 1 | 131 | 7.429688 | null | null | null | null | null | null | 3.42334 |
3,555 | 45.67297 | 1 | male | 0 | 14 | 346 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | null | null | 0 | 10,358.094 | 8,390.8359 | null | 8 | white | 14.798828 | 8 | 0.904907 | 0.839966 | 1 | 0 | 0 | no | null | null | no dnr | 14 | 85 | 4.399414 | 86 | 24 | 36.69531 | 374.9375 | 2.799805 | 0.799927 | 0.699951 | 141 | 7.389648 | null | null | null | null | null | null | 2.809082 |
3,556 | 74.29395 | 1 | female | 0 | 9 | 453 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | 7 | under $11k | 0 | 19,400.234 | 13,264.3281 | null | 25 | white | 20.199219 | 38 | 0.805908 | 0.741943 | 3 | 1 | 0 | no | 0.95 | 0.9 | no dnr | 9 | 67 | 25.097656 | 66 | 16 | 36.69531 | 194.28125 | null | 0.599976 | 1.599854 | 141 | 7.449219 | null | null | null | 0 | 5 | no(M2 and SIP pres) | 5 |
3,557 | 59.91498 | 1 | male | 0 | 28 | 301 | MOSF w/Malig | ARF/MOSF | 1 | 9 | under $11k | 0 | 51,688.625 | 36,456.1875 | null | 28.75 | black | 36.296875 | 102 | 0.269958 | 0.162994 | 2 | 0 | 0 | metastatic | 0.25 | 0.15 | dnr after sadm | 4 | 60 | 0.899902 | 200 | 35 | 39 | 277 | 2.299805 | 1.799805 | 3.699707 | 140 | 7.179688 | null | null | null | 0 | 0 | null | 0 |
3,558 | 73.57697 | 0 | male | 0 | 9 | 1,840 | Colon Cancer | Cancer | 1 | 24 | >$50k | 0 | 13,001.945 | 8,862.6719 | null | 15 | white | 19.199219 | 16 | 0.766968 | 0.517944 | 1 | 0 | 0 | metastatic | null | null | no dnr | 9 | 97 | 13.199219 | 66 | 12 | 36.69531 | 436 | null | 0.699951 | 0.799927 | 133 | 7.399414 | null | null | null | null | null | null | 2.433594 |
3,559 | 56.09598 | 0 | female | 0 | 66 | 1,826 | CHF | COPD/CHF/Cirrhosis | 3 | 9 | under $11k | 0 | 182,209.5 | 122,078.812 | null | 32 | other | 23.699219 | 22 | 0.846924 | 0.748901 | 1 | 0 | 0 | no | null | null | no dnr | 66 | 67 | 8 | 120 | 16 | 37.09375 | 356.625 | null | 1.5 | 0.899902 | 127 | 7.5 | null | null | null | 5 | 5 | SIP>=30 | 5 |
3,560 | 49.43997 | 1 | female | 0 | 6 | 128 | Colon Cancer | Cancer | 1 | 16 | >$50k | 0 | 5,030.449 | 3,832.707 | null | 13 | hispanic | 15.099609 | 5 | 0.863892 | 0.696899 | 1 | 0 | 0 | metastatic | 0.8 | 0.5 | no dnr | 6 | 83 | 8.298828 | 72 | 18 | 36.39844 | null | null | 1 | 0.899902 | 135 | null | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
3,561 | 40.81598 | 0 | male | 0 | 207 | 1,825 | CHF | COPD/CHF/Cirrhosis | 3 | 16 | $25-$50k | 0 | 548,741.5 | 357,946.75 | null | 23 | white | 18.699219 | 17 | 0.92395 | 0.871948 | 1 | 0 | 0 | no | 0.15 | 0.1 | no dnr | 207 | 63 | 7.899414 | 114 | 16 | 36.79688 | null | null | 1.199951 | 1 | 135 | null | null | null | null | 0 | 0 | SIP>=30 | 0 |
3,562 | 38.19299 | 1 | male | 0 | 24 | 290 | Cirrhosis | COPD/CHF/Cirrhosis | 1 | 14 | $11-$25k | 0 | 16,639.641 | 13,194.3906 | null | 7 | white | 30.296875 | 40 | 0.754883 | 0.611938 | 1 | 0 | 0 | no | 0.5 | 0.3 | no dnr | 24 | 89 | 4.899414 | 80 | 12 | 36.5 | 240 | 2.799805 | 5.599609 | 1.899902 | 123 | 7.5 | null | null | null | 2 | 0 | SIP>=30 | 0 |
3,563 | 62.46997 | 1 | male | 1 | 13 | 13 | CHF | COPD/CHF/Cirrhosis | 2 | 10 | $25-$50k | 0 | 26,328.797 | 18,009.0938 | null | 31 | white | 19.796875 | 16 | 0.870972 | 0.785889 | 1 | 0 | 0 | no | null | null | dnr after sadm | 10 | 69 | 11.699219 | 80 | 20 | 36.79688 | 180 | null | 1.899902 | 1.099854 | 133 | 7.489258 | null | null | null | null | 3 | <2 mo. follow-up | 3 |
3,564 | 41.09799 | 1 | male | 0 | 8 | 91 | Lung Cancer | Cancer | 1 | null | null | 0 | 5,966.547 | 4,505.6875 | null | 6.5 | white | 25.597656 | 12 | 0.575928 | 0.254944 | 1 | 0 | 0 | metastatic | 0.9 | 0.6 | no dnr | 8 | 86 | 8.199219 | 116 | 24 | 38.09375 | 366.625 | 2.799805 | 0.599976 | 0.699951 | 138 | 7.459961 | null | null | null | null | null | null | 3.006348 |
3,565 | 73.81 | 0 | male | 0 | 14 | 1,824 | COPD | COPD/CHF/Cirrhosis | 3 | null | null | 9 | 17,738.891 | 13,056.7734 | null | 14.333328 | black | 22.699219 | 20 | 0.755981 | 0.613892 | 1 | 0 | 1 | no | 0.5 | 0.3 | no dnr | 14 | 113 | 6.699219 | 114 | 12 | 36.29688 | 228.5625 | 2.899902 | null | 0.899902 | 139 | 7.349609 | null | null | null | null | null | null | 5.594727 |
3,566 | 38.36298 | 0 | male | 0 | 9 | 1,823 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 14 | $25-$50k | 0 | 15,814.742 | 12,230.4922 | null | 16 | white | 25.097656 | 53 | 0.869995 | 0.824951 | 1 | 1 | 0 | no | 0.9 | 0.85 | no dnr | 9 | 116 | 15.798828 | 82 | 26 | 36.5 | 176.65625 | 1.799805 | 0.299988 | 2.699707 | 137 | 7.5 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
3,567 | 59.20099 | 1 | male | 1 | 7 | 7 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | null | 0 | 121,286.188 | 78,953.375 | null | 23 | white | 38.59375 | 50 | 0.40094 | 0.280945 | 39 | 0 | 0 | no | 0.05 | 0.000125 | dnr after sadm | 1 | 63 | 12.099609 | 122 | 36 | 35.79688 | 195.90625 | null | null | 2.5 | 124 | 7.489258 | null | null | null | null | null | <2 mo. follow-up | 2.017578 |
3,568 | 62.64999 | 1 | male | 1 | 18 | 18 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | $25-$50k | 0 | null | null | null | 46.333313 | white | 20 | 31 | 0.861938 | 0.813965 | 1 | 0 | 0 | no | 0.6 | 0.5 | dnr after sadm | 16 | 121 | 13.099609 | 110 | 20 | 38.59375 | 215.53125 | null | 0.399963 | 1.5 | 141 | 7.439453 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
3,569 | 70.46997 | 1 | female | 0 | 7 | 439 | COPD | COPD/CHF/Cirrhosis | 3 | 6 | null | 0 | 5,841.199 | 4,553.0547 | null | 8 | black | 14.5 | 14 | 0.892944 | 0.821899 | 1 | 0 | 0 | no | 0.9 | 0.7 | no dnr | 7 | 83 | 11.398438 | 80 | 18 | 37 | 273.3125 | null | null | 1 | 141 | 7.139648 | null | null | null | 0 | 1 | null | 1 |
3,570 | 64.01099 | 0 | female | 0 | 4 | 1,821 | COPD | COPD/CHF/Cirrhosis | 1 | 12 | under $11k | 0 | 2,651.699 | 1,935.8984 | null | 11 | white | 15.699219 | 17 | 0.904907 | 0.840942 | 1 | 0 | 0 | no | null | null | no dnr | 4 | 63 | 4.5 | 80 | 22 | 36.19531 | 328.5625 | 3.399902 | 0.799927 | 0.899902 | 145 | 7.359375 | null | null | null | 4 | 6 | no(M2 and SIP pres) | 6 |
3,571 | 23.07999 | 0 | male | 0 | 6 | 1,820 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 10 | under $11k | 100 | 12,763.844 | 9,594.2344 | null | 24 | black | 16.199219 | 17 | 0.809937 | 0.745972 | 1 | 0 | 0 | no | null | null | no dnr | 6 | 106 | 7 | 72 | 32 | 39 | 205.6875 | null | 0.299988 | 1 | 134 | 7.399414 | null | null | null | null | null | no(M2 and SIP pres) | 2.512695 |
3,572 | 75.58398 | 1 | male | 1 | 19 | 19 | MOSF w/Malig | ARF/MOSF | 1 | null | null | 0 | 91,257.875 | 62,239.5938 | null | 42 | white | 40.195313 | 80 | 0.14798 | 0.070999 | 11 | 0 | 0 | yes | null | null | dnr after sadm | 17 | 123 | 0.099991 | 124 | 37 | 38.5 | 410 | null | 5 | 4.799805 | 145 | 7.479492 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
3,573 | 63.28 | 1 | male | 0 | 4 | 194 | Lung Cancer | Cancer | 1 | 12 | $11-$25k | 0 | 3,109.75 | 2,196.4746 | null | 3 | white | 16.097656 | 16 | 0.72998 | 0.458984 | 1 | 0 | 0 | metastatic | 0.7 | 0.5 | no dnr | 4 | 103 | 4.799805 | 100 | 20 | 36.29688 | null | null | 0.299988 | 1 | 139 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
3,574 | 50.47198 | 0 | female | 0 | 31 | 1,818 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | null | 0 | 59,530.938 | 40,604.875 | null | 16.25 | white | 23.398438 | 28 | 0.846924 | 0.794922 | 2 | 0 | 0 | no | 0.8 | 0.8 | no dnr | 31 | 120 | 14.798828 | 124 | 32 | 39.09375 | 226.65625 | null | null | 0.699951 | 142 | 7.479492 | null | null | null | null | null | null | 2.425293 |
3,575 | 26.53499 | 1 | female | 1 | 3 | 3 | MOSF w/Malig | ARF/MOSF | 1 | 17 | under $11k | 37 | 43,313.031 | 27,733.25 | null | 33 | white | 69.6875 | 62 | 0 | 0 | 15 | 0 | 0 | yes | null | null | dnr after sadm | 1 | 0 | 50.09375 | 0 | 0 | 38.89844 | 252.5 | 2.099609 | 1.799805 | 0.899902 | 146 | 7.449219 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
3,576 | 67.88794 | 1 | male | 0 | 12 | 28 | COPD | COPD/CHF/Cirrhosis | 2 | 8 | null | 26 | 34,118.438 | 23,141.9219 | null | 33 | white | 33.296875 | 42 | 0.417969 | 0.217987 | 1 | 0 | 0 | yes | 0.2 | 0.2 | no dnr | 12 | 121 | 14.798828 | 146 | 9 | 39.39844 | 150 | 2.599609 | 0.399963 | 0.599976 | 134 | 7.299805 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
3,577 | 76.24896 | 1 | male | 1 | 29 | 29 | COPD | COPD/CHF/Cirrhosis | 3 | 12 | under $11k | 0 | 99,316.812 | 67,983.5 | null | 40.25 | black | 25.796875 | 42 | 0.708984 | 0.54895 | 1 | 1 | 0 | no | 0.8 | 0.8 | no dnr | 29 | 143 | 6.199219 | 180 | 12 | 36.59375 | 285.6875 | 2.299805 | 0.199982 | 1 | 138 | 7.389648 | null | null | null | null | 2 | <2 mo. follow-up | 2 |
3,578 | 60.28699 | 1 | male | 0 | 7 | 99 | Lung Cancer | Cancer | 3 | 6 | >$50k | 0 | 6,261.598 | 4,410.7773 | null | 7 | white | 20.597656 | 22 | 0.643921 | 0.335999 | 1 | 0 | 0 | metastatic | 0.8 | 0.5 | no dnr | 7 | 104 | 9.898438 | 72 | 26 | 38.29688 | null | 3 | 0.299988 | 1.399902 | 135 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
3,579 | 49.26199 | 1 | female | 1 | 26 | 26 | MOSF w/Malig | ARF/MOSF | 2 | 16 | >$50k | 0 | 178,246.625 | 116,131.625 | null | 43 | white | 37.195313 | 40 | 0.263977 | 0.15799 | 16 | 0 | 0 | yes | 0.7 | 0.5 | dnr after sadm | 23 | 131 | 1.099854 | 138 | 29 | 39.89844 | 230 | 2.599609 | 6.799805 | 0.699951 | 134 | 7.429688 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
3,580 | 62.26999 | 1 | female | 1 | 30 | 30 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 18 | $11-$25k | 41 | 89,426.625 | 60,591.3438 | null | 31.5 | black | 36.59375 | 69 | 0.362 | 0.244995 | 1 | 0 | 0 | no | 0.2 | 0.15 | no dnr | 30 | 59 | 11.298828 | 124 | 45 | 39.09375 | 128.3125 | 2.699707 | null | 2.099609 | 158 | 7.459961 | null | null | null | null | 5 | <2 mo. follow-up | 5 |
3,581 | 62.004 | 0 | female | 0 | 10 | 1,814 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | null | null | 0 | 14,802.898 | 10,652.4844 | null | 25 | white | 36.296875 | 37 | 0.391968 | 0.195984 | 1 | 0 | 0 | no | null | null | no dnr | 10 | 47 | 12.798828 | 64 | 16 | 34.69531 | 110.20312 | 2.099609 | 0.399963 | 0.699951 | 141 | 7.439453 | null | null | null | null | null | null | 3.069336 |
3,582 | 48.32898 | 1 | male | 0 | 3 | 638 | COPD | COPD/CHF/Cirrhosis | 3 | null | null | 0 | 3,862.049 | 2,818.4746 | null | 7 | black | 18.597656 | 31 | 0.929932 | 0.880981 | 1 | 0 | 0 | no | null | null | no dnr | 3 | 81 | 4.699219 | 80 | 28 | 36.79688 | 190.46875 | 3.199707 | 0.5 | 0.899902 | 142 | 7.279297 | null | null | null | null | null | null | 2.43457 |
3,583 | 70.23096 | 1 | female | 0 | 27 | 51 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 14 | under $11k | 0 | 61,871.781 | 42,937.25 | null | 31 | white | 18.597656 | 27 | 0.8479 | 0.795898 | 2 | 0 | 0 | no | 0.85 | 0.85 | no dnr | 27 | 63 | 14.199219 | 72 | 24 | 36.69531 | 211.40625 | null | null | 1.5 | 136 | 7.419922 | null | null | null | 1 | 1 | <2 mo. follow-up | 1 |
3,584 | 66.297 | 1 | female | 0 | 6 | 317 | Colon Cancer | Cancer | 1 | 12 | $11-$25k | 0 | 5,967 | 4,048.7168 | null | 12 | white | 10.099609 | 6 | 0.889893 | 0.747925 | 1 | 0 | 0 | metastatic | 0.8 | 0.6 | no dnr | 6 | 97 | 7.299805 | 100 | 16 | 37.59375 | null | 4 | 0.299988 | 0.699951 | 141 | null | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
3,585 | 69.62396 | 1 | male | 0 | 15 | 143 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 16 | >$50k | 0 | 38,503.188 | 27,377.5 | null | 25 | white | 29.597656 | 41 | 0.655884 | 0.556885 | 3 | 0 | 0 | no | 0.5 | 0.25 | no dnr | 15 | 67 | 12.5 | 110 | 14 | 38.59375 | 120.40625 | null | null | 2.199707 | 144 | 7.509766 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
3,586 | 54.409 | 0 | male | 0 | 3 | 1,812 | CHF | COPD/CHF/Cirrhosis | 3 | 14 | >$50k | 0 | 4,717.898 | 3,261.6523 | null | 11 | white | 13.798828 | 18 | 0.931885 | 0.883911 | 1 | 0 | 0 | no | null | null | no dnr | 3 | 78 | 6.5 | 84 | 18 | 36.79688 | null | 4.299805 | 4 | 0.699951 | 146 | null | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
3,587 | 52.03598 | 1 | female | 0 | 5 | 387 | Colon Cancer | Cancer | 1 | 21 | null | 0 | 4,229.547 | 2,943.043 | null | 13 | white | 19.597656 | 16 | 0.805908 | 0.585938 | 1 | 0 | 0 | metastatic | 0.9 | 0.5 | no dnr | 5 | 105 | 5.099609 | 120 | 20 | 39 | null | null | 0.5 | 0.599976 | 142 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
3,588 | 63.33499 | 1 | male | 0 | 6 | 396 | Colon Cancer | Cancer | 1 | 8 | $25-$50k | 0 | 5,371.25 | 3,912.6953 | null | 9 | white | 28.398438 | 30 | 0.606934 | 0.290955 | 1 | 0 | 0 | metastatic | 0.9 | 0.6 | no dnr | 6 | 47 | 5.099609 | 60 | 12 | 35.09375 | null | null | 0.5 | 0.899902 | 140 | null | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
3,589 | 20.605 | 1 | female | 0 | 90 | 92 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | null | 0 | 152,497.25 | 102,769.375 | null | 29.25 | black | 30 | 39 | 0.852905 | 0.80188 | 2 | 0 | 0 | no | 0.95 | 0.95 | no dnr | 90 | 77 | 6.199219 | 40 | 8 | 36.19531 | 187.5 | null | 3.099609 | 2.099609 | 147 | 7.509766 | null | null | null | null | 0 | null | 0 |
3,590 | 62.52698 | 1 | male | 0 | 7 | 1,302 | CHF | COPD/CHF/Cirrhosis | 3 | 22 | $25-$50k | 0 | 2,618.5 | 2,440.3203 | null | 4.5 | white | 15.898438 | 22 | 0.903931 | 0.838989 | 1 | 0 | 0 | no | 0.9 | 0.8 | no dnr | 7 | 79 | 4.699219 | 70 | 18 | 36 | null | null | 0.899902 | 1.299805 | 141 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
3,591 | 53.81 | 1 | male | 0 | 6 | 589 | CHF | COPD/CHF/Cirrhosis | 4 | 7 | under $11k | 0 | 4,520.699 | 3,556.5644 | null | 10 | black | 16.597656 | 11 | 0.915894 | 0.856934 | 1 | 0 | 0 | no | null | null | no dnr | 6 | 85 | 6 | 78 | 22 | 36.09375 | 368 | null | 1.5 | 1 | 133 | 7.459961 | null | null | null | 4 | null | null | 3.183199 |
3,592 | 42.24799 | 1 | male | 0 | 11 | 201 | CHF | COPD/CHF/Cirrhosis | 3 | 13 | $11-$25k | 0 | 18,666.984 | 13,877.7188 | null | 22.5 | black | 31.796875 | 38 | 0.789917 | 0.662964 | 1 | 0 | 0 | no | 0.8 | 0.6 | no dnr | 11 | 47 | 4.599609 | 112 | 28 | 35.39844 | 224 | null | 1.5 | 1 | 134 | 7.489258 | null | null | null | 5 | 0 | null | 0 |
3,593 | 52.13998 | 0 | female | 0 | 19 | 1,811 | ARF/MOSF w/Sepsis | ARF/MOSF | 6 | 14 | under $11k | 0 | null | null | null | 16.666656 | white | 27.296875 | 51 | 0.727905 | 0.643921 | 3 | 0 | 0 | yes | 0.9 | 0.85 | no dnr | 19 | 163 | 5.5 | 118 | 38 | 37.79688 | 245.6875 | null | 0.199982 | 5.299805 | 140 | 7.479492 | null | null | null | null | 6 | no(M2 and SIP pres) | 6 |
3,594 | 69.08398 | 1 | male | 1 | 7 | 7 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 37 | 95,429.812 | 60,088.8125 | null | 42 | black | 30.199219 | 46 | 0.41095 | 0.291992 | 13 | 0 | 0 | no | 0.5 | 0.5 | no dnr | 7 | 76 | 27.199219 | 118 | 10 | 36.09375 | 363.3125 | null | 2.199707 | 2.399902 | 152 | 7.419922 | null | null | null | null | null | <2 mo. follow-up | 2.517578 |
3,595 | 63.35699 | 1 | male | 0 | 8 | 89 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 0 | 15,985.195 | 11,313.6406 | null | 23.5 | black | 35.59375 | 55 | 0.586914 | 0.477966 | 1 | 0 | 0 | no | null | null | no dnr | 8 | 57 | 4 | 148 | 24 | 35.89844 | 352.375 | null | 1.899902 | 2.699707 | 132 | 7.439453 | null | null | null | null | null | null | 2.844238 |
3,596 | 83.24194 | 1 | female | 0 | 15 | 85 | CHF | COPD/CHF/Cirrhosis | 2 | 12 | under $11k | 0 | 16,066.695 | 12,339.7422 | null | 15.666664 | black | 23.597656 | 24 | 0.740967 | 0.592896 | 1 | 0 | 0 | no | null | null | no dnr | 15 | 83 | 5.799805 | 60 | 16 | 36 | 163.25 | null | 2.699707 | 1.5 | 140 | 7.359375 | null | null | null | null | 0 | adl>=4 (>=5 if sur) | 0 |
3,597 | 57.28699 | 1 | female | 0 | 22 | 322 | Lung Cancer | Cancer | 1 | 10 | $11-$25k | 0 | 23,456.391 | 16,489.7344 | null | 11 | white | 20.898438 | 21 | 0.644897 | 0.337952 | 1 | 0 | 0 | metastatic | 0.8 | 0.5 | no dnr | 22 | 76 | 9.199219 | 108 | 28 | 36.29688 | 319 | null | 0.699951 | 0.699951 | 143 | 7.399414 | null | null | null | 6 | null | null | 4.527397 |
3,598 | 46.65799 | 0 | female | 0 | 19 | 1,806 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 9 | null | 44 | 39,171.875 | 28,236.4219 | null | 23 | black | 26.597656 | 50 | 0.661987 | 0.564941 | 4 | 0 | 0 | no | 0.9 | 0.9 | no dnr | 19 | 145 | 17.699219 | 110 | 32 | 38.59375 | 376.1875 | null | 1.099854 | 8.199219 | 132 | 7.419922 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
3,599 | 42.935 | 1 | male | 1 | 7 | 7 | Coma | Coma | 0 | null | null | 100 | 21,663.938 | 14,849.8281 | null | 30.5 | black | 17.398438 | 12 | 0.569946 | 0.50293 | 3 | 0 | 0 | no | null | null | no dnr | 7 | 78 | 17 | 54 | 12 | 38 | 323.3125 | null | null | 0.799927 | 142 | 7.5 | null | null | null | null | null | <2 mo. follow-up | 2.086914 |
3,600 | 65.24597 | 1 | male | 0 | 9 | 15 | MOSF w/Malig | ARF/MOSF | 2 | null | null | 9 | 18,175.234 | 14,276.125 | null | 13 | white | 26.699219 | 25 | 0.522949 | 0.406982 | 1 | 0 | 0 | metastatic | 0.25 | 0.1 | no dnr | 9 | 103 | 14.898438 | 64 | 12 | 36.5 | 116 | null | 0.599976 | 0.699951 | 136 | 7.489258 | null | null | null | null | null | <2 mo. follow-up | 3.376953 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.